The World Anti-Doping Agency (WADA) has implemented the 2025 List of Prohibited Substances and Methods as of 1 January 2025
128 However, no further research appears to have confirmed these promising results
Innovations like GLP-1 patches represent additional delivery innovations that could reduce costs while improving patient adherence
These unregulated products, sometimes marketed as semaglutide peptides, are not approved for human use and lack safety testing
doi: 10.3389/fphar.2023.1122632 Received 13 December 2022 Accepted 13 March 2023 Published 27 March 2023 Volume 14 - 2023 Edited by Enrico Sangiovanni, University of Milan, Italy Reviewed by Ayaz Shahid, Western University of Health Sciences, United States Andres A
MS (ESI) m/z: 796.42, found 797.43 [M + H] +